YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Investors interested in Medical Services stocks are likely familiar with Progyny (PGNY) and Charles River Laboratories (CRL). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer…
Charles River Laboratories International CRL has witnessed strong momentum over the past year. Shares of the company have risen 75.8%, outperforming the industry's 10.5% growth. The S&P 500 composite has increased 16.1% during the same tim…
Q2 Earnings Roundup: UFP Technologies (NASDAQ:UFPT) And The Rest Of The Drug Development Inputs & Services Segment The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a l…
Teleflex's TFX Vascular business is well-positioned for growth in the upcoming quarters, led by sustained demand for central access and hemostatic products, coupled with new product introductions such as EZPLAZ. Further, the company's expa…
Partnership reinforces continued investment in digitization, automation, and client-facing transparency WILMINGTON, Mass. & LONDON, October 06, 2026--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and Autolomou…
Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Invesco S&P 500 Equal Weight Health Care ETF (RSPH), a passively managed exchange traded fund launched on November 1, 2006. Passivel…
Price targets for Charles River Laboratories International have shifted higher in recent research, with several firms now pointing to a range between US$219 and US$340, alongside a new fair value estimate of US$305. That cluster of higher…
Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST) Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Today we…
Company Logo Animal model demand is rising with drug and vaccine research. CRISPR, AI and humanized models offer opportunities, while ethical scrutiny spurs humane alternatives. Dublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "Animal Model - Gl…
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Aveanna Healthcare (AVAH) been one of those stocks this year? A quick glance at the company's year-…
Cooke & Bieler, an investment management firm, released its second-quarter investor letter for "Mid Cap Value Equity Strategy." The letter can be downloaded here. U.S. equities rallied significantly in Q2, driven by shifting geopolitical r…
Company Logo Stricter quality rules, complex biologics and outsourcing are driving demand for impurity isolation, synthesis and analytics, creating opportunities for specialized labs and CROs. Dublin, Sept. 29, 2026 (GLOBE NEWSWIRE) -- "Ph…
Company Logo AI, machine learning, cloud analytics and multi-omics are accelerating drug discovery, enabling targeted, personalized therapies while reducing development time, cost and risk. Dublin, Sept. 29, 2026 (GLOBE NEWSWIRE) -- "Compu…
PMGC Holdings Inc. Engagement of a leading global contract research organization strengthens the analytical foundation supporting EL-22 and EL-32 as the programs advance toward an IND-enabling development framework Builds on NorthStrive Bi…
Company Logo Boost ROI by matching models to research goals, standardizing studies, investing in quality data and training, integrating validated AI and alternatives, and aligning global partnerships Dublin, Sept. 29, 2026 (GLOBE NEWSWIRE)…
CareDx CDNA shares ended the last trading session 13% higher at $61.37. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 6.6% gain over the past f…
Charles River Laboratories International has seen its share price move sharply over the past year, and that kind of run naturally raises a question for you as an investor. Are the cash flows that the business can generate enough to support…
Why Charles River Laboratories (CRL) Stock Is Up Today What Happened? Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 5.7% in the afternoon session after the company outlined long-term financial targets through…
Company Logo Opportunities center on AI-enabled decentralized trials, therapeutic specialization, global patient recruitment, regulatory support, real-world evidence and integrated partnerships. Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "…
Company Logo Opportunities include validated AI, cloud safety platforms, real-world evidence, integrated pharmacovigilance, patient-centric reporting and expansion in emerging markets. Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Drug Safet…
–Outlines Pathway to Purpose Strategy to Modernize the Company, Strengthen Its Scientific Portfolio, and Enhance the Client Experience – –Issues Long-Term Financial Targets through 2030 – –Reaffirms 2026 Financial Guidance with Revenue and…
Company Logo Pharma R&D outsourcing is rising as CROs use AI, genomics and advanced screening to cut costs, accelerate discovery, improve compliance and support targeted therapies. Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Drug Discovery…
Company Logo Demand for outsourced pharmacokinetics services is rising, driven by AI, advanced bioanalysis, personalized medicine, biologics and complex global trials. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Pharmacokinetics Services -…
3 Unpopular Stocks Walking a Fine Line When Wall Street turns bearish on a stock, it's worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other busine…
Company Logo Stricter safety rules, drug innovation and CRO outsourcing drive demand, while imaging, CRISPR and data analytics improve testing and reduce animal use. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "In Vivo Toxicology - Global S…
Company Logo Pharma companies are expanding drug discovery outsourcing to cut costs, access CRO expertise and AI tools, speed pipelines, manage regulatory complexity, and advance targeted therapies. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE)…
Company Logo Stricter safety rules and drug innovation are boosting demand, while high-throughput screening, predictive analytics, biomarkers, and non-animal methods create new opportunities. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Tox…
Company Logo AI-driven screening, advanced imaging and demand for targeted therapies are accelerating FBDD, creating opportunities in oncology, neurology and traditionally undruggable targets. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Fr…
Company Logo PDX adoption is rising as pharma seeks predictive oncology models for precision medicine, biomarker discovery and drug screening, supported by sequencing advances and research partnerships. Dublin, Sept. 22, 2026 (GLOBE NEWSWI…
Company Logo Demand is rising for faster, accurate ADME-Tox testing, driven by complex biologics, tighter regulation, personalized medicine, and adoption of high-throughput, in vitro and in silico methods. Dublin, Sept. 22, 2026 (GLOBE NEW…
On August 20, Charles River Laboratories (NYSE:CRL) announced a collaboration with Medigen Vaccine Biologics Corp/MVC to apply next-generation sequencing to MVC's new multivalent enterovirus vaccine program. On its own, the deal is small.…
On September 8, Charles River Laboratories (NYSE:CRL) said its newly automated cartridge manufacturing suite for Endosafe endotoxin testing had reached full operational capacity in the third quarter, a milestone it had been building toward…
Riverwater Partners, an investment management company, released its 'Sustainable Value Strategy' Q2 2026 investor letter. The letter can be downloaded here. Small-cap stocks achieved their best first-half performance since 1991, with the R…
Charles River Laboratories International (CRL) just rolled out rapid cell banking programs built around Next-Generation Sequencing and its Pathoquest acquisition, aiming to shorten development timelines for advanced therapies and strengthe…
Investors looking for stocks in the Medical Services sector might want to consider either Progyny (PGNY) or Charles River Laboratories (CRL). But which of these two stocks presents investors with the better value opportunity right now? Let…
Charles River Laboratories International (NYSE:CRL) unveiled new rapid cell banking and release programs that use advanced sequencing and in vitro tools. The platform is designed to shorten biologics and advanced therapy cell bank lead tim…